A comparative study of dyslipidaemia in men and woman with androgenic alopecia
Autoria(s):
Arias-Santiago, Salvador; Gutierrez-Salmeron, Maria Teresa; Buendia-Eisman, Agustin; Giron-Prieto, Maria Sierra; Naranjo-Sintes, Ramon
Data(s)
21/12/2011
21/12/2011
01/09/2010
Resumo
Several studies have analyzed the relationship between androgenetic alopecia and cardiovascular disease (mainly heart disease). However few studies have analyzed
lipid values in men and women separately. This case-control study included 300 patients consecutively admitted to an outpatient clinic, 150 with early onset
androgenetic alopecia (80 males and 70 females) and 150 controls (80 males and 70
females) with other skin diseases. Female patients with androgenic alopecia
showed significant higher triglycerides values (123.8 vs 89.43 mg/dl, p = 0.006),
total cholesterol values (196.1 vs 182.3 mg/dl, p = 0.014), LDL-C values (114.1
vs 98.8 mg/dl, p = 0.0006) and lower HDL-C values (56.8 vs 67.7 mg/dl, p <0.0001)
versus controls respectively. Men with androgenic alopecia showed significant
higher triglycerides values (159.7 vs 128.7 mg/dl, p = 0.04) total cholesterol
values (198.3 vs 181.4 mg/dl, p = 0.006) and LDL-C values (124.3 vs 106.2, p =
0.0013) versus non-alopecic men. A higher prevalence of dyslipidemia in women and
men with androgenic alopecia has been found. The elevated lipid values in these
patients may contribute, alongside other mechanisms, to the development of
cardiovascular disease in patient with androgenic alopecia.
Identificador
Arias-Santiago S, Sanchez-Cano D, Callejas-Rubio JL, Fernández-Pugnaire MA, Ortego-Centeno N. Adalimumab treatment for SAPHO syndrome. Acta Derm Venereol. 2010 May;90(3):301–2.